Magnetic Iron Oxide Nanoparticles for Magnetic Particle Imaging

Technology #17354

Questions about this technology? Ask a Technology Manager

Download Printable PDF

Professor Moungi Bawendi
Department of Chemistry, MIT
External Link (
Professor Ou Chen
Department of Chemistry, Brown University
External Link (
He Wei
Department of Chemistry, MIT
Oliver Bruns
Department of Chemistry, MIT
Managed By
Jim Freedman
MIT Technology Licensing Officer - Chemicals, Instruments, Consumer Products
Patent Protection

Nanoparticles for magnetic particle imaging applications

US Patent Pending 2016-0136307

Nanoparticles for magnetic particle imaging applications

PCT Patent Application WO 2016-077769


Magnetic particle imaging (MPI) is a tomographic imaging technique in which superparamagnetic, iron oxide nanoparticles are injected into the bloodstream, generating magnetic fields that are measured to produce 3D images. The inventors have developed monodisperse and highly magnetic large iron-oxide nanoparticles to increase the MPI signal strength.

Problem Addressed

MPI offers more advanced imaging than other commonly used techniques such as magnetic resonance imaging (MRI), with high sensitivity and resolution along with near-perfect contrast due to the diamagnetic nature of human tissue. MPI signal strength and efficiency are dependent on the synthesis and size control of large magnetic nanoparticles. The currently used MPI contrast agent, Resovist, has a limited signal strength similar to that of 3% iron oxide nanoparticles with a ~30 nm inorganic diameter. The inventors have developed monodisperse and highly magnetic large iron oxide nanoparticles that are expected to improve the existing MPI signal strength by over 90% .


These large magnetite (Fe3O4) magnetic nanoparticles are prepared by decomposing iron oleate precursors at high temperature (290°C – 390 °C). The high reaction temperature encourages the formation of larger nanoparticles. Upon completion, the nanoparticles are precipitated by adding chloroform and acetone, centrifuged, and re-dispersed and stored in hexane.

The resulting ~35 nm iron oxide nanoparticles become water soluble upon deposition of a hydrophilic silica shell. The silica shell is formed on the surface of nanoparticles by decomposing tetraethyl orthosilicate (TEOS) in a cyclohexane solvent in the presence of Igepal CO-520 and ammonium hydroxide. The resulting  iron oxide/silica shell nanoparticles have an inorganic diameter of ~50 nm and can be dispersed in water and phosphate buffered saline. The nanoparticles are coated by polyethelene glycol derivatives such as methoxy polyethylene glycol silane to improve their long-term stability in aqueous media. 


  • Large iron oxide nanoparticles demonstrate 90% increased MPI signal strength
  • Particles display good stability in aqueous media